Nizac

nizatidine

Nizac is a Prescription medicine


Main Indication

Nizac is indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks. Nizac is also indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. Continuous therapy with nizatidine for longer than 1 year has not been studied. Nizac is indicated for up to 8 weeks for the treatment of benign gastric ulcer. Nizac is indicated for up to 12 weeks for the treatment of oesophagitis, including erosive and ulcerative oesophagitis and associated heartburn due to reflux.

Therapeutic Area

Gastroenterology

Sponsored By: Aspen Australia

Medical Queries: 1300 659 646

Nizac is available in these strengths:

  • Nizac 150mg Capsules
  • Nizac 300mg Capsules
Product Information for Nizac
Consumer Medicine Information for Nizac